« FDA and Researchers Move Us Closer to New Clinical Model(s) | Main | Raw Material Detectives - coming this week - Case #1 »

04/23/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013480178f23970c

Listed below are links to weblogs that reference Pass/Fail Grades from the Clinic:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce Lehr

Pharmaceutical Business Review reports on EU approval for Tarceva as a maintenance therapy for patients with non-small cell lung cancer (NSCLC).
http://regulatoryaffairs.pharmaceutical-business-review.com/news/roche_gets_ec_approval_for_tarceva_100429/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada